Signal from the log
Atlas Bio
10 M$ · Seed · Switzerland · Biotech
Atlas Bio, société suisse, entraîne un modèle d'IA sur environ deux millions de mesures d'ARN de tissus humains pour simuler l'effet d'un médicament chez des patients virtuels, avant la phase 2 et à la place d'une partie des essais sur l'animal. La levée de seed est menée par Creandum.
Article
Announced on , logged by the watch of 27 October 2026.
- Operation
- Funding round
- Announced amount
- 10 M$
- Stage
- Seed
- Country
- Switzerland
- Sector
- Biotech
What the log says
Editorial note, in French
Sujet traité. L'article donne les sources et la position de Bolus.
The investors
Led by Creandum
Provenance
Source tech-eu,techfundingnews
Logged on 27 October 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Article The operation led to an article, with its sources checked one by one.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.